Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Weiss

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Chemistry & Biology|February 28, 2012
TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in huntington's diseaseBarbara Baldo, Paolo Paganetti, Stephan Grueninger, et al.
European Biophysics Journal : EBJ|September 29, 2004
A new method to determine the structure of the metal environment in metalloproteins: investigation of the prion protein octapeptide repeat Cu(2+) complexMatthias Mentler, Andreas Weiss, Klaus Grantner, et al.
Nature Communications|October 25, 2016
Targeted inhibition of the COP9 signalosome for treatment of cancerAnita Schlierf, Eva Altmann, Jean Quancard, et al.
The Journal of Biological Chemistry|May 31, 2015
Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in VivoRobert O'Brien, Francesco DeGiacomo, Jennifer Holcomb, et al.
The Journal of Biological Chemistry|January 21, 2010
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington diseaseChristian Landles, Kirupa Sathasivam, Andreas Weiss, et al.
The Journal of Clinical Investigation|November 20, 2012
Mutant huntingtin impairs immune cell migration in Huntington diseaseWanda Kwan, Ulrike Träger, Dimitrios Davalos, et al.
Human Molecular Genetics|October 27, 2012
Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3)Jeannette Hübener, Jonasz Jeremiasz Weber, Claudia Richter, et al.
Human Molecular Genetics|October 12, 2014
Comparative study of naturally occurring huntingtin fragments in Drosophila points to exon 1 as the most pathogenic species in Huntington's diseaseBrett A Barbaro, Tamas Lukacsovich, Namita Agrawal, et al.
Plos One|September 7, 2012
K-RAS mutant pancreatic tumors show higher sensitivity to MEK than to PI3K inhibition in vivoIrmgard Hofmann, Andreas Weiss, Gaelle Elain, et al.
Neurobiology of Disease|December 3, 2014
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse modelsUlrike Träger, Ralph Andre, Anna Magnusson-Lind, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Chemistry & Biology|February 28, 2012
TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in huntington's diseaseBarbara Baldo, Paolo Paganetti, Stephan Grueninger, et al.
European Biophysics Journal : EBJ|September 29, 2004
A new method to determine the structure of the metal environment in metalloproteins: investigation of the prion protein octapeptide repeat Cu(2+) complexMatthias Mentler, Andreas Weiss, Klaus Grantner, et al.
Nature Communications|October 25, 2016
Targeted inhibition of the COP9 signalosome for treatment of cancerAnita Schlierf, Eva Altmann, Jean Quancard, et al.
The Journal of Biological Chemistry|May 31, 2015
Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in VivoRobert O'Brien, Francesco DeGiacomo, Jennifer Holcomb, et al.
The Journal of Biological Chemistry|January 21, 2010
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington diseaseChristian Landles, Kirupa Sathasivam, Andreas Weiss, et al.
The Journal of Clinical Investigation|November 20, 2012
Mutant huntingtin impairs immune cell migration in Huntington diseaseWanda Kwan, Ulrike Träger, Dimitrios Davalos, et al.
Human Molecular Genetics|October 27, 2012
Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3)Jeannette Hübener, Jonasz Jeremiasz Weber, Claudia Richter, et al.
Human Molecular Genetics|October 12, 2014
Comparative study of naturally occurring huntingtin fragments in Drosophila points to exon 1 as the most pathogenic species in Huntington's diseaseBrett A Barbaro, Tamas Lukacsovich, Namita Agrawal, et al.
Plos One|September 7, 2012
K-RAS mutant pancreatic tumors show higher sensitivity to MEK than to PI3K inhibition in vivoIrmgard Hofmann, Andreas Weiss, Gaelle Elain, et al.
Neurobiology of Disease|December 3, 2014
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse modelsUlrike Träger, Ralph Andre, Anna Magnusson-Lind, et al.
Pageof 11